Detalhe da pesquisa
1.
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
N Engl J Med
; 389(24): 2221-2232, 2023 Dec 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37952131
2.
Semaglutide and Cardiovascular Outcomes. Reply.
N Engl J Med
; 390(8): 768-769, 2024 Feb 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38381687
3.
Drugs for Treating Obesity.
Handb Exp Pharmacol
; 274: 387-414, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-34783910
4.
Evidence-based weight loss interventions: Individualized treatment options to maximize patient outcomes.
Diabetes Obes Metab
; 23 Suppl 1: 50-62, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32969147
5.
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design.
Am Heart J
; 229: 61-69, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32916609
6.
Energy Balance and Weight Loss for Diabetes Remission.
Diabetes Spectr
; 33(2): 117-124, 2020 May.
Artigo
Inglês
| MEDLINE | ID: mdl-32425448
7.
Fiber Intake Predicts Weight Loss and Dietary Adherence in Adults Consuming Calorie-Restricted Diets: The POUNDS Lost (Preventing Overweight Using Novel Dietary Strategies) Study.
J Nutr
; 149(10): 1742-1748, 2019 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31174214
8.
Management of obesity.
Lancet
; 387(10031): 1947-56, 2016 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26868660
9.
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
N Engl J Med
; 369(2): 145-54, 2013 Jul 11.
Artigo
Inglês
| MEDLINE | ID: mdl-23796131
10.
Body mass index and the risk of all-cause mortality among patients with type 2 diabetes mellitus.
Circulation
; 130(24): 2143-51, 2014 Dec 09.
Artigo
Inglês
| MEDLINE | ID: mdl-25378546
11.
Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial.
J Nutr
; 145(6): 1289-94, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25926410
12.
Assessment and lifestyle management of patients with obesity: clinical recommendations from systematic reviews.
JAMA
; 312(9): 943-52, 2014 Sep 03.
Artigo
Inglês
| MEDLINE | ID: mdl-25182103
13.
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial.
Nat Med
; 2024 May 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38740993
14.
Pharmacologic treatment options for obesity: what is old is new again.
Curr Hypertens Rep
; 15(3): 182-9, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23625271
15.
Lifestyle-Based Obesity Care.
Gastroenterol Clin North Am
; 52(4): 645-660, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37919018
16.
Prioritizing obesity treatment: expanding the role of cardiologists to improve cardiovascular health and outcomes.
Cardiovasc Endocrinol Metab
; 12(1): e0279, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36777095
17.
Trends in obesity prevalence and cardiometabolic risk factor control in US adults with diabetes, 1999-2020.
Obesity (Silver Spring)
; 31(3): 841-851, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36697975
18.
Effects of an oral biodegradable device used for 12 weeks on weight reduction, cardiovascular risk factors, satiety, snacking, and meal size.
Obes Pillars
; 8: 100094, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38125654
19.
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics.
Obesity (Silver Spring)
; 31(1): 111-122, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36502289
20.
Weighing up dietary patterns - Authors' reply.
Lancet
; 388(10046): 759-60, 2016 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-27560275